Fintel reports that on January 8, 2025, TD Cowen upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy.

Shares of Cardinal Health Inc. CAH inched 0.93% higher to $122.53 Wednesday, on what proved to be an all-around favorable ...

This is the fourth industrial property the buyer has acquired in Grove City over the last two weeks. A Cardinal Health ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60.

Cardinal Health (CAH – Research Report) received a Buy rating and a $144.00 price target from TD Cowen analyst Charles Rhyee today. The ...

TD Cowen upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $144, up from $130. The firm believes new customers, strong ...

Here are five recent updates on the five biggest GI chains, as reported by Becker's: Dallas-based GI Alliance entered a definitive agreement with Dublin, Ohio-based pharmaceutical distributor and ...

Evercore ISI has upgraded Cardinal Health (NYSE:CAH) to outperform from in line, citing the company's improved outlook. The ...

BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting ...

The clinic was part of a nationwide movement of doctors and other medical workers calling in sick to protest war in the ...

Saeed Sadeghi, MD, discusses valuable feedback he heard from oncologists on the use of luspatercept-aamt in patients with low-risk myelodysplastic syndrome.